tadliq

Generic: tadalafil

Labeler: cmp pharma, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name tadliq
Generic Name tadalafil
Labeler cmp pharma, inc.
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

tadalafil 20 mg/5mL

Manufacturer
CMP Pharma, Inc.

Identifiers & Regulatory

Product NDC 46287-045
Product ID 46287-045_cf6ec62b-5d5e-49ed-8d46-8a759d0e2b93
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA214522
Listing Expiration 2026-12-31
Marketing Start 2022-08-30

Pharmacologic Class

Established (EPC)
phosphodiesterase 5 inhibitor [epc]
Mechanism of Action
phosphodiesterase 5 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 46287045
Hyphenated Format 46287-045

Supplemental Identifiers

RxCUI
2613563 2613569
UNII
742SXX0ICT
NUI
N0000175599 N0000020026

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tadliq (source: ndc)
Generic Name tadalafil (source: ndc)
Application Number NDA214522 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/5mL
source: ndc
Packaging
  • 150 mL in 1 BOTTLE (46287-045-15)
source: ndc

Packages (1)

46287-045-15 150 mL in 1 BOTTLE (46287-045-15)

Ingredients (1)

tadalafil (20 mg/5mL)

Linked Drug Pages (1)

TADLIQ ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "cf6ec62b-5d5e-49ed-8d46-8a759d0e2b93", "openfda": {"nui": ["N0000175599", "N0000020026"], "unii": ["742SXX0ICT"], "rxcui": ["2613563", "2613569"], "spl_set_id": ["7a909b25-3772-403e-a5fe-e4a040293fb7"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["CMP Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "150 mL in 1 BOTTLE (46287-045-15)", "package_ndc": "46287-045-15", "marketing_start_date": "20220830"}], "brand_name": "TADLIQ", "product_id": "46287-045_cf6ec62b-5d5e-49ed-8d46-8a759d0e2b93", "dosage_form": "SUSPENSION", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "46287-045", "generic_name": "Tadalafil", "labeler_name": "CMP Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TADLIQ", "active_ingredients": [{"name": "TADALAFIL", "strength": "20 mg/5mL"}], "application_number": "NDA214522", "marketing_category": "NDA", "marketing_start_date": "20220830", "listing_expiration_date": "20261231"}